Navigation Links
Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors
Date:3/31/2009

CAMBRIDGE, Mass., March 31 /PRNewswire/ -- Fina Technologies, Inc. today announced that it named Dr. Christopher Ahlberg, a pioneering entrepreneur and scientist, and founder of Spotfire, Inc., to its Board of Directors.

Dr. Ahlberg most previously was Executive Vice President, Tibco, Inc., and President of Tibco's Spotfire division, dating back to 2007. Prior to TIBCO, Dr. Ahlberg was the founder and CEO of Spotfire, Inc., a provider of enterprise analytics software for next generation business intelligence and scientific applications. Dr. Ahlberg was named among the World's Top Young Innovators by Technology Review, MIT's Magazine of Innovation, in 2002. Dr. Ahlberg earned his doctorate from Chalmers University of Technology, has worked as a visiting researcher at the University of Maryland, and has lectured and consulted extensively for industry, academia, and the military -- as well as published and lectured in computer science, psychology, linguistics, biology, and chemistry.

"Fina Technologies has a unique opportunity to leverage Gene Network Sciences' REFS(TM) model learning and simulation platform, which has been used in biological systems for several years, to gain an advantage in quantitative finance," said Dr. Ahlberg. "I am looking forward to using my experience with these types of data to help Fina push this application forward."

Dr. Ahlberg also serves as a Board member of Apptus Technologies AB and the Hult International Business School.

"Christopher will be an invaluable asset to Fina, given his experience in building Spotfire, from the startup phase onward," said Josh Holden, CEO of Fina Technologies. "We will fully utilize his insights and intuition as to how to best apply and develop our technology for our applications."

About Fina Technologies

Fina Technologies, Inc. is a spinoff of Gene Network Sciences (GNS) focused on applying the REFS(TM) model learning and simulation platform and other machine-learning tools to large-data problems in the worlds of finance and other non-biomedical areas. Fina Technologies applies massively parallel supercomputing technology combined with cutting edge machine learning techniques to create quantitative trading algorithms and deliver business solutions for a new class of massively data intensive applications.


'/>"/>
SOURCE Fina Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Recent ... cell type. Many treatments for specific cancers, such as breast, prostate, or lung, ... is androgen deprivation therapy for advanced prostate cancer. , This therapy limits ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar ... has secured $2M in funding from an impressive group of investors, including Rev1 ... Thrive Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering ...
(Date:8/16/2017)... edition of the Inc. 5000 features a now-familiar name: BioPoint ( http://biopointinc.com/ ... list for the third year in a row. Now in its 36th ... a set of quantitative metrics. In addition, BioPoint was also named to ... Bay State . ... ...
(Date:8/15/2017)... , Aug. 15, 2017 After spending the past ... support with crowdsourced data collection, GeneFo now offers this platform to ... aligning and amplifying support, adherence, and data collection vis a vis ... foundations mark the successful launch of this offer. ... GeneFo ...
Breaking Biology Technology:
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):